The Operating Theatre Journal - Journal - Page 28
ZEISS Presents New Surgical Workflow Innovations at ASCRS
New products help doctors diagnose and treat patients within the cataract and corneal refractive workflows.
ZEISS Medical Technology will showcase new surgical workflow
innovations at the American Society of Cataract and Refractive Surgery
(ASCRS) annual conference from May 6-8, 2023, in San Diego, CA.
These products as part of the ZEISS Medical Ecosystem help enhance
ophthalmic care within the cataract and corneal refractive workflows
for improved diagnosis and treatment efficiency of surgical patients:
• The ATLAS™ 500 from ZEISS supports more efficient surgical
diagnostics enhancing patient outcomes.
ZEISS VISULAS yag laser
• The CT LUCIA® 621P Monofocal IOL from ZEISS received U.S. FDA
approval, offering a unique ZEISS Optic to treat a wide range of
cataract patients.
• With more than 7 million eyes treated with SMILE® worldwide, the
ZEISS LVC portfolio helps create a high vision standard in laser vision
correction.
• The VISULAS® yag laser from ZEISS delivers high-precision treatment
for a high variety of IOL conditions.
Offering a unique ZEISS Optic to treat a wide range of
cataract patients in the U.S.
ZEISS delivers intuitive equipment and consumables to support reliable
patient outcomes for a wide range of cataract patients. The CT LUCIA®
621P Monofocal IOL from ZEISS recently received U.S. FDA approval,
featuring a patented ZEISS Optic (ZO) Asphericity Concept designed to
compensate for a wide range of spherical aberrations and at the same
time optimize visual outcomes in the event of potential decentration
and lens misalignments. The ZEISS CT LUCIA 621P also comes in a fully
preloaded injector for an intuitive, smooth, and controlled injection.
Additionally, the architecture of the IOL is designed to enable easy
centering while maximizing direct capsular contact, thus ensuring
stability and supporting a consistent position in the bag.
ZEISS ATLAS 500 with monitor
“We are excited to offer
these innovations to help
maximize surgical workflow
efficiency and performance,
and further transform patient
care in ophthalmology,”
said Euan S. Thomson,
PhD, President of the
Ophthalmology Strategic
Business Unit and Head of the
Digital Business Unit for ZEISS
Medical Technology. “ZEISS
believes in a fully connected
and integrated approach to
eye care, and we continue to
focus on the development of
workflow solutions that will
improve the quality of life for
patients.”
ZEISS CT LUCIA 621P
Monofocal IOL
Supporting more efficient surgical diagnostics for
better patient outcomes
With more than 25 years of experience in corneal topography, the
ATLAS™ 500 from ZEISS is the next-generation corneal topographer
capable of the imaging and measurement of the cornea for assessment
of various pathologies. The ATLAS 500 provides an intuitive and wellorganized interface for efficient operation and workflow-optimized
visualization. It integrates into both the corneal refractive and cataract
workflows.
28
“The line has been blurred between refractive and cataract surgery –
for us surgeons that means we must always be raising our game to get
patients the visual outcomes they expect. When I tell patients they are
going to receive a ZEISS intraocular lens, ZEISS is a name they know and
see as synonymous with quality giving them confidence in the product
and the procedure. The ZEISS legacy in optics is great for surgeons
because we know they make incredible lenses and great equipment
too,” said Sydney L. Tyson, M.D., Ophthalmologist, Cataract & LASIK
Surgeon, and Founder of Eye Associates & SurgiCenter of Vineland
(USA).
Creating a high standard in laser vision correction
ZEISS celebrates a new milestone with more than 7 million eyes treated
with SMILE® worldwide, building on its claim as a leader in laser vision
correction with one of the most comprehensive LVC portfolios in the
industry. The ZEISS portfolio creates a high vision standard while
enabling surgeons to grow their business and provide broader choices
and a viable solution in refractive surgery to any eligible patient.
SMILE® is a minimally invasive corneal refractive procedure performed
by using the VisuMax® femtosecond laser creating a thin disc-shaped
lenticule within the cornea, which is then removed through a small
incision, thereby achieving the desired vision correction.
Delivering high-precision treatment for a high variety
of IOL conditions
The VISULAS® yag laser from ZEISS is a modern and compact laser
workstation that offers high-precision treatment for safe and effective
photodisruption. The laser uses an infrared light to perform posterior
capsulotomy for a high variety of IOLs and peripheral iridotomy. Its
high-precision super gaussian beam focuses laser energy offered in 22
levels with optimal gradation onto the point of treatment. Based on the
selected application, the automated focus shift sets the focal point of
the aiming beam precisely in front of, behind or directly at the focal
point of the disruption laser.
ZEISS will showcased its new surgical workflow solutions during the
American Society of Cataract and Refractive Surgery (ASCRS) Annual
Conference from May 6-8, 2023, at booth 1437.
For more information, visit www.zeiss.com/med.
THE OPERATING THEATRE JOURNAL
When responding to articles please quote ‘OTJ’
www.otjonline.com